Bionano Genomics (BNGO) Net Margin (2017 - 2026)

Bionano Genomics has disclosed Net Margin across 10 years of filings, most recently posting 90.85% for Q2 2026.

• In Q2 2026, Net Margin rose 1100.0% year-over-year to 90.85%; the TTM figure through Jun 2026 stood at 88.44% (up 9831.0% YoY), while the FY2025 annual figure was 73.39%, up 21549.0% from the prior year.
• Net Margin came in at 90.85% for Q2 2026 at Bionano Genomics, up from 124.17% in the prior quarter.
• In the past five years, Net Margin ranged from a high of 36.59% in Q4 2024 to a low of 1208.05% in Q3 2023.
• Average Net Margin over 5 years is 347.61%, with a median of 383.86% recorded in 2024.
• Year-over-year, Net Margin tumbled 76754 bps in 2023 and surged 61315 bps in 2025.
• Over 5 years, Net Margin stood at 470.81% in 2022, then rose by 13 bps to 409.39% in 2023, then surged by 109 bps to 36.59% in 2024, then plunged by 185 bps to 30.93% in 2025, then plunged by 194 bps to 90.85% in 2026.
• Per Business Quant data, the three most recent Net Margin figures were 90.85% in Q2 2026, 124.17% in Q1 2026, and 30.93% in Q4 2025.